IMAC Holdings, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US44967K3023
USD
0.18
0.13 (233.33%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About IMAC Holdings, Inc. stock-summary
stock-summary
IMAC Holdings, Inc.
Pharmaceuticals & Biotechnology
IMAC Holdings, Inc. is a provider of movement and orthopedic therapies and minimally invasive procedures performed through its regenerative and rehabilitative medical treatments. The Company operates innovative medical advancements and care (IMAC) regeneration centers, which combines life science with medical care for movement restricting diseases and conditions. Its outpatient medical clinics focuses on treating sports and orthopedic injuries and movement-restricting diseases without surgery or opioids. The Company’s outpatient medical clinics provides minimally invasive medical treatments to help patients with back pain, knee pain, joint pain, ligament and tendon damage, and other related soft tissue conditions. It partners with athletes and operates Ozzie Smith IMAC Regeneration Centers, David Price IMAC Regeneration Centers, Mike Ditka IMAC Regeneration Centers and Tony Delk IMAC Regeneration Center. The Company owns and manages approximately 15 outpatient clinics.
Company Coordinates stock-summary
Company Details
1605 Westgate Cir , BRENTWOOD TN : 37027
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 2 Schemes (1.15%)

Foreign Institutions

Held by 1 Foreign Institutions (0.55%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-2 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 0 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.19

stock-summary
Return on Equity

81.92%

stock-summary
Price to Book

-0.03